Bremer Pharma ceases to be subsidiary of Cadila Healthcare
Cadila Healthcare has divested its entire shareholding in Bremer Pharma GmbH, Germany (Bremer), a wholly owned subsidiary of the company and consequently, Bremer ceased to be a subsidiary of the company.The company received consideration at enterprise value of Euro 22,63,431 of which share sale value is Euro 8,27,344 and loan value (extended by Zydus International - a wholly owned subsidiary of the company) is Euro 14,36,087.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
